A carregar...
Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data
BACKGROUND: The X‐ACT study aimed to examine the effect of omalizumab treatment on quality of life (QoL) in chronic spontaneous urticaria (CSU) patients with angioedema refractory to high doses of H(1)‐antihistamines. METHODS: In X‐ACT, a phase III, double‐blind, placebo‐controlled study, CSU patien...
Na minha lista:
| Publicado no: | Allergy |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5836932/ https://ncbi.nlm.nih.gov/pubmed/29058822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.13339 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|